Journal article

Pneumococcal vaccination for HIV-infected individuals in Singapore

PV Licciardi, EL Tan, P Li, OT Ng

Proceedings of Singapore Healthcare | Published : 2019


Susceptibility to infections with pneumococcal bacteria (Streptococcus pneumoniae) is substantially higher among human immunodeficiency virus (HIV)-infected individuals, and accounts for a significant burden of morbidity and healthcare costs. Pneumococcal vaccination is recommended in most countries for HIV-infected adults. Current policy in Singapore and Australia recommends the use of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) as a booster dose following the use of 13-valent pneumococcal conjugate vaccine (PCV13). Despite this, adherence to this policy has been suboptimal in Singapore. This may be related to the fact that PPSV23 has not been shown to have any impact on pneu..

View full abstract